A B S T R A C T Inheritance of the gene for 8E_globin is associated with hypochromia and microcytosis, reminiscent of typical heterozygous 8-thalassemia. Pa 
INTRODUCTION
Hemoglobin (Hb)l E (f826 Glu-*LYS) is the third most common hemoglobin variant worldwide; it is particularly prevalent among Southeast Asian individuals (1) (2) (3) . Individuals heterozygous (Hb E trait) or homozygous (Hb E disease) for Hb E exhibit microcytosis and erythrocyte morphology resembling p-thalassemia trait (1) (2) (3) . Double heterozygosity for Hb E and p-thalassemia is frequently associated with a moderately severe ,p-thalassemia syndrome, the molecular basis of which has not been well defined (2) (3) (4) (5) . It has been suggested that the thalassemia-like phenotype of Hb E disorders results from impaired synthesis of iE_globin (6) (7) (8) (9) (10) , or, perhaps from I3E_globin chain instability (11, 12) . Either mechanism could result in a limited supply of the abnormal f8-globin chain and lead to decreased net accumulation of Hb E. To define more precisely the pathogenesis of Hb Table I . Patient 1, a Vietnamese, had severe, transfusion-dependent anemia phenotypically simulating classical homozygous f3-thalassemia. Patient 2,  of Thai extraction, had a 13-thalassemia intermedia phenotype, with marked hypochromic, microcytic anemia and hepatosplenomegaly, but no chronic transfusion requirement. Neither patient had undergone splenectomy. Both exhibit typical thalassemic facies, growth retardation, and erythroid hyperplasia. Patients with Hb S-,8-thalassemia and "classical" /3-thalassemia who were studied have been described previously (13) (14) (15) (16) . In addition, the father ofpatient 1, a heterozygote for Hb E, was studied (Table I) . Other family members were unavailable for detailed study.
Preparation and radioactive labeling of reticulocytes. Erthrocytes from 50 ml of peripheral blood were collected by centrifugation at 2,000 rpm for 10 min at 2-4°C in a Sorvall RC-3 centrifuge (DuPont Instruments, Newtown, Conn.); the cells were washed three times in sterile isotonic saline. About 5 ml of cells was set aside in an ice bath for incubation with either [uS]methionine or [3H]leucine. The remainder of the cell pellet was suspended in ice-cold 5 mM magnesium chloride, shaken vigorously, and incubated for 1 min on ice. The hemolysates were then extracted with phenol for preparation of reticulocyte RNA, using methods previously described (17) . (18) ; the suspension was preincubated for 5 min at 370C with gentle shaking prior to the addition of isotope. For short-term, pulse-chase labeling studies, 200 ACi of [3H]leucine was added to 3 cm3 of prewarmed cell suspension. The incubation was allowed to proceed for 1 or 5 min at 37°C in a shaking waterbath, at which time aliquots of 200 ,ul were removed and quickly frozen in acetone-dry ice for later globin analysis. 10 mM nonradioactive leucine was added to the remaining cell suspension, and the sample rapidly chilled in an ice-waterbath. The cells were pelleted at 0°C for 5 min at 2,000 rpm in a Sorvall RC-3 centrifuge, and the cell pellet was resuspended in prewarmed incubation mixture containing 10 mM nonradioactive leucine, at a hematocrit of 30-35% . "Chase" incubations were then conducted at 37°C in a shaking waterbath for the times indicated in the text. At each time point, a 400-,ul aliquot was removed, quick-frozen, and stored at -800C for globin chain analysis. Long-term incubations of reticulocytes from patient 1 were conducted similarly, except that the radioactive precursor was [u5S]methionine (sp act 4 mmol, 200
,uCi/ml cell suspension).
Globin chain analysis. Each cell pellet from the pulsechase labeling experiment was thawed in an equal volume of ice-cold 5 mM magnesium chloride, and the resulting hemolysate either used directly to prepare globin or clarified by centrifugation for 30 s at 12,000 rpm in an Eppendorftabletop centrifuge (Eppendorf Geratebau, Netherler, West Germany). Globin was prepared by acid-acetone precipitation, and globin chains were separated and quantitated by carboxymethylcellulose chromatography, using methods which we have described in detail elsewhere (17, 19) . In preliminary experiments, we verified that the globin chain biosynthetic ratios of clarified lysates were essentially equal to studies, the measured non-a/a ratios were doubled, to account for the presence of two methionine ratios in a-globin, but only one in the relevant non-a globins (20) . The production of 3E_globin by both patients was also verified by "fingerprint" mapping of peptides resulting from tryptic digests of nonradioactive globin from each patient, using methods previously described in detail (21) . Globin from both patients yielded the characteristic fingerprint of patients producing both pA-and 1E_globins: loss of intensity from the (iT3 peptide spot, and generation of two new spots, one of which is detectable by arginine staining. In both cases, the two new spots migrated in the characteristic positions of ,3E_globin. These results were entirely typical of patients heterozygous for pA-and 1E_globin. In addition, a portion of the radioactive globin from both patients comigrated with authentic ,3E_globin marker on carboxymethylcellulose columns.
Extraction and analysis of reticulocyte RNA. Total reticulocyte cellular RNA was prepared by phenol extraction and alcohol precipitation as described previously by this laboratory (17, 19) . RNA was desalted by centrifugation through a Sephadex G-25 (coarse) syringe column (22) , and used directly for further analysis without purification of globin mRNA fractions. Cell-free translations in wheat germ extracts were performed utilizing methods described in detail elsewhere, as was molecular hybridization analysis, utilizing radioactive, purified a-and ,8-globin cDNA hybridization probes (13) (14) (15) (16) (17) 19 ). Globin chains synthesized in cell-free translation systems primed with reticulocyte RNA were analyzed by carboxymethylcellulose chromatography after addition of authentic globin chain markers, as described in the preceding section. ,3/a mRNA ratios assessed by molecular hybridization were obtained by saturation hybridization analysis, comparing the slopes obtained from titration of equal amounts of a-and /8-cDNA by increasing amounts of each RNA sample, as described elsewhere (14) (15) (16) . However, hybridization reactions were conducted under conditions which we have previously shown (14) (15) (16) to prohibit cross-hybridization among /8-, 8-, e-, and -y-mRNA and cDNA sequences. The molecular hybridization analyses do not distinguish between ,A_ and 3E_mRNA, since these mRNA most likely differ only in one or a few base pairs. Traeger and co-workers (23) have recently observed that f3E_mRNA hybridizes efficiently to /8-cDNA probes with properties identical to ours. The hybridization assay thus measures the total content of/8-mRNA sequences relative to a-mRNA (i.e., /3A + /E/a mRNA) and does not allow individual quantitation of the relative amounts of/3A_ and /E-mRNA (i.e., /E//3AmRNA). Therefore, deficiency of,BE_mRNA can be inferred only ifthe /3A + /3E/a mRNA ratio is too low to be due solely to the I3AmRNA produced by the normal (/3A) or 3thaL_gene present in trans to the 3E_gene.
RESULTS
Characteristics of patients and initial rates of globin biosynthesis. Analysis of reticulocyte globin mRNA. Total cellular RNA prepared from reticulocytes of each patient was translated into globin chains in a wheat germ extract cell-free system, as noted in Methods. The globin biosynthetic ratios observed by this technique were similar to those observed in intact cells for patient 1 (cf. Fig. 3 ). Precise quantitation of globin biosynthetic ratios could not be computed for patient 2 because of relatively high background nonglobin radioactivity comigrating in this region of chromatogram. However, the 'BE/a ratio, including the nonglobin peaks, remained clearly <0.30 with this mRNA preparation. These data are summarized in Table IV. The level of 13E_globin synthesis in the cell-free translation system primed with mRNA from the proband was substantially lower than the levels of fs3 globin synthesis obtained from studies of two patients with Hb S-f3-thalassemia (see also reference 30, 31). These experiments indicate that a defect in the amount and/or function of I3E_globin mRNA occurs in these reticulocytes, and is sufficiently severe to account for reduced I3E-globin production.
To obtain more reliable quantitative data concerning the actual chemical amounts of a-and ,B-globin mRNA in reticulocytes from the probands, saturation hybridization analysis was performed as described in Methods and shown in Fig. 5 . Under the conditions of hybridization employed, cross-hybridization between f3E-globin mRNA and IB3A-globin cDNA is virtually 100%, since a single base mutation does not appreciably alter the stability of RNA-cDNA hybrids in this system (23) . The assay does not permit individual quantitation of I3A_mRNA relative to 8E_ mRNA. In contrast, we have repeatedly shown (13) (14) (15) (16) that the hybridization conditions employed reproducibly detect 83-mRNA without cross-hybridization to y-mRNA. RNA from both patients exhibited a striking decrease in the total /3 globin mRNA content (i.e., /3A + JJE/a ratio). The total /3a mRNA ratios observed were 0.28 for patient 1, 0.20 for patient 2, and 0.49 in the patient with Hb E trait (Fig. 6) (9, 10) , despite mild instability demonstrable in vitro (32, 33) .
Our studies of family 1 (Figs. 1 and 3 , Table III) patients with homozygous 3-thalassemia were derived from our previous studies (13) (14) (15) (16) served by lowering a-globin and a-globin mRNA. The recently described condition in which more than the normal number of a-genes are inherited (34) could conceivably account for our data if the extra a-genes were functional. However, these genes do not appear to alter a-and /8-globin balance in patients studied thus far (35) . In any event, this hypothesis cannot explain the lower production of /3E_globin than /3A_globin in heterozygotes. Hb E is an example of an increasing number of structurally abnormal globins that are also synthesized at abnormally low rates. The Hb Lepore and Hb Constant Spring hemoglobins (2, 3, 35) are the best known examples. More recently, Hb Indianapolis, a /-chain mutant, has been shown to produce /8-thalassemia by profound posttranslational instability of the newly assembled ,8-variant, preventing combination with a-globin to form hemoglobin tetramers (18) . Finally, we have described a profound reduction in the mRNA coding for the ,8-chain of Hb Vicksburg (/375 beu0 ), which exhibits a /8-thalassemia phenotype (39) .
Our studies do not explain the mechanism for the thalassemia-like behavior of /3E_globin genes. It is difficult to envision a precise mechanism whereby the presumed single nucleotide change responsible for the amino acid substitution at position 26 should cause lower globin mRNA production. However, the location of the mutation in codon 26, near the junction of mRNA coding and intervening sequences at codon 30, could lead to disruption of intranuclear mRNA processing, a mechanism now known to be responsible for some forms of /8-thalassemia (36) (37) (38) . Alternatively, the mutation could disrupt the secondary structure of /3E_mRNA, causing instability or decreased template capacity with consequent instability, mechanisms also implicated in /-thalassemia (35) . Finally, Hb E could represent a "double mutation," i.e., base substitution occurring on a pre-existing /3-thalassemia allele, a /8-thalassemia occurring on a /3E_globin allele, or a recombination event between two such alleles. These occurrences would not be surprising within a population where both conditions are so frequent. The high frequency of Hb E in Southeast Asia could conceivably result from selection for the /3-thalassemia phenotype. The amino acid substitution in Hb E may be an incidental feature "carried" through evolution by the same mechanism that preserves /-thalassemia in many groups. Further exploration of these possibilities can be achieved by studies of mRNA metabolism and restriction endonuclease polymorphisms, using gene blotting techniques (35) .
